DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Afinitor (Everolimus) - Current Clinical Trials

 
 



Afinitor Related Clinical Trials

Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium [Recruiting]

RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer [Recruiting]

Everolimus (RAD001) in Primary Therapy of Waldenstrom's Macroglobulinemia [Recruiting]

Radiation Therapy (IMRT) + RAD001 (Everolimus) + Cisplatin for Patients With Head and Neck Cancer [Recruiting]

Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity [Recruiting]

Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC [Recruiting]

Everolimus(RAD001) For Advanced Renal Cell Carcinoma(RCC)Before Kidney Removal [Recruiting]

Phase II Trial of RAD001 in Patients With Recurrent Low Grade Glioma [Recruiting]

A Study to Determine the Effectiveness of Escalating Doses of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis [Recruiting]

RAD001 for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas [Recruiting]

Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC) [Recruiting]

Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies [Recruiting]

A Safety Study of LBH589 (Panobinostat) and RAD001 (Everolimus) to Stabilize Kidney Cancer [Recruiting]

A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer [Recruiting]

Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer [Recruiting]

Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer [Recruiting]

Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial Carcinoma [Recruiting]

Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory Lymphoma [Recruiting]

Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2 [Not yet recruiting]

Dose Finding Study of RAD001 (Everolimus, Afinitor´┐Ż) in Combination With BEZ235 in Patients With Advanced Solid Tumors [Recruiting]

Study of RAD001 (Everolimus) for Children With NF1 and Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomas [Recruiting]

Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) [Recruiting]

Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC) [Recruiting]

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma [Recruiting]

Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane [Not yet recruiting]

A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers [Recruiting]

Everolimus, Bortezomib and/or Rituximab in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia [Recruiting]

Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex [Not yet recruiting]

Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC) [Recruiting]

Erlotinib and Temsirolimus for Solid Tumors [Recruiting]

Sirolimus as Therapeutic Approach to Uveitis [Recruiting]

A Study of mTOR Inhibitor Everolimus (RAD001) in Association With Cisplatin and Radiotherapy for Locally Advanced Cervix Cancer [Recruiting]

Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer [Recruiting]

Everolimus Rescue Immunosuppression in the Treatment of Chronic Allograft Dysfunction in Renal Transplant Recipients [Recruiting]

Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer [Not yet recruiting]

Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab in Adult Patients With Kidney Cancer [Recruiting]

Certican« (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients [Recruiting]

RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia [Recruiting]

Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma [Recruiting]

Everolimus and Low Dose CNI Compared With MMF and Full CNI Dose in Heart Transplanted Patients: One Year Follow up [Not yet recruiting]

Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia [Recruiting]

Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular Carcinoma [Recruiting]

RAD001 Salvage Monotherapy in Advanced Gastric Cancer (AGC) Who Failed Standard First-Line Treatment [Recruiting]

Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer [Recruiting]

Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer [Recruiting]

Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer [Recruiting]

STORM: Temsirolimus, Rituximab and DHAP for Relapsed and Refractory Diffuse Large B-cell Lymphoma [Recruiting]

Bevacizumab, Temsirolimus, Valproic Acid, Cetuximab [Recruiting]

Sirolimus for Autoimmune Disease of Blood Cells [Recruiting]

Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer [Recruiting]

Rapamycin and Regulatory T Cells in Kidney Transplantation [Recruiting]

Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer [Recruiting]

Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS) [Recruiting]

Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients [Recruiting]

Study of Everolimus (RAD001, Afinitor«) for Children With Recurrent or Progressive Ependymoma [Not yet recruiting]

Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer [Recruiting]

A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis [Recruiting]

Temsirolimus in Combination With Metformin in Patients With Advanced Cancers [Recruiting]

Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma [Recruiting]

Anakinra or Denosumab and Everolimus in Advanced Cancer [Recruiting]

Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI [Recruiting]

Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer [Recruiting]

Differentiating Everolimus Versus Sirolimus in Combination With Calcineurin Inhibitors in Kidney Transplant Patients [Recruiting]

Vandetanib With Everolimus [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014